BRD2492
BRD2492 (compound 6d) is a potent, selective HDAC1 and HDAC2 inhibitor with IC50s of 13.2 nM and 77.2 nM, respecrtively. BRD2492 exhibits >100-fold selectivity for HDAC1/2 over selectivity over HDAC3 and HDAC6. BRD2492 inhibits breast cancer cell lines growth with IC50s of 1.01 μM and 11.13 μM for T-47D and MCF-7 cells, respectively[1].
Product Specifications
CAS Number
1821669-43-5
UNSPSC
12352005
Target
HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/brd2492.html
Purity
99.18
Solubility
DMSO : 31.25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(NC1=C(N)C=CC(C2=CC=NC=C2)=C1)C3=CC=C(NC(C)=O)C=C3
Molecular Formula
C20H18N4O2
Molecular Weight
346.38
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC1; HDAC2; HDAC3; HDAC6
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![12 Lipoxygenase (ALOX12) Mouse Monoclonal Antibody [Clone ID: OTI1C3]](https://cdn.genprice.uk/products/937/68dd18b9061270361e908166/imageurl/cf807718.webp)
12 Lipoxygenase (ALOX12) Mouse Monoclonal Antibody [Clone ID: OTI1C3]
Hepatocyte Specific (CPS1/1022), CF647 conjugate, 0.1mg/mL
